Location

Hyatt Regency Denver at Colorado Convention Center
Capitol Ballroom 4 • 650 15th Street, Denver, Colorado

Date & Time

Friday, May 10, 2013  •  6:00AM-7:45AM

Program Description

This interactive educational breakfast symposium has been developed to evaluate the safety and efficacy of catheter-based renal sympathetic denervation for the treatment of resistant hypertension; and its emergence as an optimal therapeutic approach in the management of atrial fibrillation and ventricular arrhythmias

The leading faculty experts will evaluate the future of renal denervation within daily practice, including; evidence of efficacy, its therapeutic expansion, technological advancements, as well as review renal denervation clinical trial data.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Program Director

Larry Chinitz, MD
Director, Clinical Cardiac Electrophysiology
New York University Medical Center
New York, NY

Faculty

Gerhard Hindricks, MD, PhD
University of Leipzig
Leipzig, Germany

Douglas Packer, MD
Professor of Medicine
Mayo Clinic
Rochester, MN

Kalyanam Shivkumar, MD, PhD, FHRS
Professor of Medicine & Radiological Sciences
UCLA Cardiac Arrhythmia Center & EP Programs
UCLA Health System, David Geffen School of Medicine at UCLA
Los Angeles, CA

Agenda

Target Audience

This activity has been developed to meet the educational needs of Electrophysiologists, Cardiologists and other Physicians and Associated professionals managing patients with cardiac arrhythmias and heart failure.

Learning Objectives

Upon completion of this educational activity, participants will be able to:

• Assess the safety and efficacy of renal denervation for the treatment of resistant hypertension, and its role in the management of atrial fibrillation and ventricular arrhythmias.
• Evaluate patient identification and selection criteria for determining renal denervation candidates.
• Review renal denervation clinical trial data.

Commercial Support

This activity is supported by an educational grant from

Sponsor

Accreditation Statement

This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through joint sponsorship of MediaSphere Medical, LLC and Cine-Med. Cine-Med is accredited by the ACCME to provide continuing medical education for Physicians.

Cine-Med designates this educational activity for a maximum of 1 AMA PRA CATEGORY 1 Credits(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

MediaSphere Medical designates this educational activity for 1 Contact Hour. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy

It is the policy of MediaSphere Medical and Cine-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Cine-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Faculty disclosures will be made available on the course syllabus book and faculty introductory slides.

This program is not part of the Heart Rhythm 2013 Official Scientific Sessions as planned by the Heart Rhythm Society Scientific Sessions Program Committee. This event is neither sponsored nor endorsed by the Heart Rhythm Society